These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 505529)

  • 1. Problems with a walking donor transfusion program.
    Kakaiya RM; Morrison FS; Halbrook JC; Rawson JE; Lotz LL
    Transfusion; 1979; 19(5):577-80. PubMed ID: 505529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a walking-donor blood transfusion program in an intensive care nursery.
    Pass MA; Johnson JD; Schulman IA; Grumet CF; Hafleigh EB; Malachowski NC; Sunshine P
    J Pediatr; 1976 Oct; 89(4):646-51. PubMed ID: 182947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Blood Donor Sex on Transfusion-Related Outcomes in Preterm Infants.
    Murphy T; Chawla A; Tucker R; Vohr B
    J Pediatr; 2018 Oct; 201():215-220. PubMed ID: 29784518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A walking blood donor program for seriously ill premature infants.
    Hattersley PG; Goetzman BW; Gross S; Blankenship WJ
    Transfusion; 1976; 16(4):366-9. PubMed ID: 951734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood transfusion practices and blood-banking services in a Kenyan hospital.
    Lackritz EM; Ruebush TK; Zucker JR; Adungosi JE; Were JB; Campbell CC
    AIDS; 1993 Jul; 7(7):995-9. PubMed ID: 8357559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood components in neonatal medicine.
    Hill RM; Tennyson LM; Cabrera-Meza G
    South Med J; 1984 Aug; 77(8):965-7. PubMed ID: 6463695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P): A research program striving to improve blood donor safety and optimize transfusion outcomes across the lifespan.
    Josephson CD; Glynn S; Mathew S; Birch R; Bakkour S; Baumann Kreuziger L; Busch MP; Chapman K; Dinardo C; Hendrickson J; Hod EA; Kelly S; Luban N; Mast A; Norris P; Custer B; Sabino E; Sachais B; Spencer BR; Stone M; Kleinman S;
    Transfusion; 2022 May; 62(5):982-999. PubMed ID: 35441384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a strategy to limit blood donor exposure in high risk premature newborns based on clinical estimation of transfusion need.
    van Straaten HL; de Wildt-Eggen J; Huisveld IA
    J Perinat Med; 2000; 28(2):122-8. PubMed ID: 10875097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial assessing the feasibility and safety of biologic parents as RBC donors for their preterm infants.
    Strauss RG; Burmeister LF; Johnson K; Cress G; Cordle DG
    Transfusion; 2000 Apr; 40(4):450-6. PubMed ID: 10773058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pedi-pack transfusion in a newborn intensive care unit.
    Kakaiya RM; Morrison FS; Rawson JE; Lotz LL; Martin JW
    Transfusion; 1979; 19(1):19-24. PubMed ID: 432909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing donor exposure in preterm infants requiring multiple blood transfusions.
    Wood A; Wilson N; Skacel P; Thomas R; Tidmarsh E; Yale C; de Silva M
    Arch Dis Child Fetal Neonatal Ed; 1995 Jan; 72(1):F29-33. PubMed ID: 7743280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A walking donor program for an intensive care nursery.
    Blankenship WJ; Goetzman BW; Gross S; Hattersley PG
    J Pediatr; 1975 Apr; 86(4):583-5. PubMed ID: 805222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel strategy to limit blood donor exposure and blood waste in multiply transfused premature infants.
    Wang-Rodriguez J; Mannino FL; Liu E; Lane TA
    Transfusion; 1996 Jan; 36(1):64-70. PubMed ID: 8607157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant erythropoietin and blood transfusion in selected preterm infants.
    Meyer MP; Sharma E; Carsons M
    Arch Dis Child Fetal Neonatal Ed; 2003 Jan; 88(1):F41-5. PubMed ID: 12496225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transfusion risks and alternatives to transfusion].
    de Stasio G
    Recenti Prog Med; 1992 Jun; 83(6):321-9. PubMed ID: 1496180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction of a donor exposure reduction programme for multiple-transfused very-low-birth-weight infants.
    Kirsten GF; Kirsten CL; Faber M; Collett C; Mitchell CA; Bird AR
    S Afr Med J; 1996 Nov; 86(11 Suppl):1460-4. PubMed ID: 9180796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Blood Transfusion From Female Donors With and Without a History of Pregnancy With Mortality Among Male and Female Transfusion Recipients.
    Caram-Deelder C; Kreuger AL; Evers D; de Vooght KMK; van de Kerkhof D; Visser O; Péquériaux NCV; Hudig F; Zwaginga JJ; van der Bom JG; Middelburg RA
    JAMA; 2017 Oct; 318(15):1471-1478. PubMed ID: 29049654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic umbilical cord blood red cell concentrates: an innovative blood product for transfusion therapy of preterm infants.
    Bianchi M; Giannantonio C; Spartano S; Fioretti M; Landini A; Molisso A; Tesfagabir GM; Tornesello A; Barbagallo O; Valentini CG; Vento G; Zini G; Romagnoli C; Papacci P; Teofili L
    Neonatology; 2015; 107(2):81-6. PubMed ID: 25401961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor exposure rate to transfusion ratio: a better discriminator of improvement in neonatal transfusion practice.
    Ibojie J; Greiss M; Lloyd DJ; Urbaniak SJ
    Transfus Med; 2003 Oct; 13(5):287-91. PubMed ID: 14617339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.